News

Latest News | 18 April 2013

FDA Gets Go-Ahead for Study of DTC Advertising and Social Media

0 Likes

The US Food and Drug Administration (FDA) will move forward with a survey of healthcare professionals regarding their opinions and perceptions about prescription drug promotion after receiving Read More...

---

Latest News | 8 March 2013

FDA Announces Reorganization of Advertising Regulators, Will Divide Into Product Specialties

1 Likes

US regulators are preparing to reorganize the Office of Prescription Drug Promotion (OPDP), the first major change to the office since its promotion to a super office and a name change from the Read More...

---

Latest News | 19 February 2013

Could the Claim of 'Crazyballs' Constitute a Promotional Claim and Violate Federal Law?

2 Likes

The patient is male, middle-aged and has just suffered a massive heart attack. For now, he’s sedated, covered by blue cloth and being operated on by a female surgeon, with another attending surgeon Read More...

---

Latest News | 4 December 2012

In Landmark Ruling, Court Sees Off-Label Marketing as Protected Free Speech

1 Likes

In a potentially landmark ruling, the US 2nd Circuit Court of Appeals has reversed a lower court's finding that a pharmaceutical sales representative was guilty of promoting off-label uses for certain Read More...

---

Latest News | 29 November 2012

Woodcock Announces New Leader for CDER Compliance Office

0 Likes

One of FDA's top pharmaceutical regulatory officials is getting a promotion.In an email sent to staff on Wednesday, 28 November, Janet Woodcock, director of FDA's Center for Drug Evaluation and Read More...

---

Latest News | 6 July 2012

Pfizer Receives Untitled Letter for Presentation of Drug Risks

0 Likes

The US Food and Drug Administration’s (FDA) Office of Prescription Drug Promotion (OPDP) recently sent an untitled letter to pharmaceutical manufacturing giant Pfizer for allegedly marketing its Read More...

---

Latest News | 27 June 2012

US Regulators Move Ahead With Planned Study on DTC Marketing

1 Likes

How long does it take for the US Food and Drug Administration (FDA) to get a study up and running? For at least one previously-proposed study on promotional advertising, nearly two years.Since Read More...

---

Latest News | 12 June 2012

FDA Gets Permanent Director for Reorganized Surveillance 'Super Office'

0 Likes

The US Food and Drug Administration (FDA) has announced the promotion of Gerald Dal Pan, MD to the position of permanent director of FDA’s Office of Surveillance and Epidemiology (OSE), where Dal Pan Read More...

---

Latest News | 11 April 2012

Report: Regulations Banning Industry Gifts in India Still Taking Shape

0 Likes

A set of long-awaited pharmaceutical marketing rules preventing companies operating in India from providing free products to doctors in order to drive sales has failed to take shape a year after the Read More...

---

Latest News | 3 April 2012

MHRA Publishes New Edition of 'Blue Guide' on Medicinal Advertising, Promotion

0 Likes

The Medicines and Healthcare products Regulatory Agency (MHRA) 3 April announced 3 April it has published a draft of the third edition of its Blue Guide—a guide to the advertising and promotion of Read More...

---